Patents by Inventor Geir KILDAHL-ANDERSEN

Geir KILDAHL-ANDERSEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted phenazines and methods of treating cancer and bacterial diseases
    Patent number: 11958842
    Abstract: A combination product comprising a carbapenem and a compound of formula (I?), or a pharmaceutically acceptable salt thereof: a pharmaceutical composition comprising the combination product; and methods of treating bacterial or fungal infections using the combination product and pharmaceutical composition.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: April 16, 2024
    Assignee: ADJUTEC PHARMA AS
    Inventors: Pål Rongved, Ove Alexander Høgmoen Åstrand, Elvar Ørn Viktorsson, Ørjan Samuelson, Adam Heikal, Ole Andreas Løchen Økstad, Geir Kildahl-Andersen
  • Compounds
    Patent number: 11649222
    Abstract: The invention provides compounds for use in a method of treating and/or preventing a bacterial infection in a human or non-human mammal, said method comprising administration of said compound in combination with (either simultaneously, separately, or sequentially) a ?-lactam antibiotic, wherein said compound has the general formula I: (wherein: Q is a lipophilic, zinc chelating moiety which is selective for Zn2+ ions and which comprises at least one, preferably two or more (e.g 2, 3 or 4), optionally substituted, unsaturated heterocyclic rings, e.g.
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: May 16, 2023
    Assignee: UNIVERSITETET I OSLO
    Inventors: Pål Rongved, Ove Alexander Høgmoen Åstrand, Ørjan Samuelsen, Christian Schnaars, Geir Kildahl-Andersen
  • COMPOUNDS
    Publication number: 20210221791
    Abstract: The invention provides compounds for use in a method of treating and/or preventing a bacterial infection in a human or non-human mammal, said method comprising administration of said compound in combination with (either simultaneously, separately, or sequentially) a ?-lactam antibiotic, wherein said compound has the general formula I: Q?L-W]X??(I) (wherein: Q is a lipophilic, zinc chelating moiety which is selective for Zn2+ ions and which comprises at least one, preferably two or more (e.g 2, 3 or 4), optionally substituted, unsaturated heterocyclic rings, e.g.
    Type: Application
    Filed: December 17, 2020
    Publication date: July 22, 2021
    Inventors: Pål RONGVED, Ove Alexander Høgmoen ÅSTRAND, Ørjan SAMUELSEN, Christian SCHNAARS, Geir KILDAHL-ANDERSEN
  • Compounds
    Patent number: 10961223
    Abstract: The invention provides compounds for use in a method of treating and/or preventing a bacterial infection in a human or non-human mammal, said method comprising administration of said compound in combination with (either simultaneously, separately, or sequentially) a ?-lactam antibiotic, wherein said compound has the general formula I: (I) (wherein: Q is a lipophilic, zinc chelating moiety which is selective for Zn2+ ions and which comprises at least one, preferably two or more (e.g 2, 3 or 4), optionally substituted, unsaturated heterocyclic rings, e.g.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: March 30, 2021
    Assignee: UNIVERSITETET I OSLO
    Inventors: Pål Rongved, Ove Alexander Høgmoen Åstrand, Ørjan Samuelsen, Christian Schnaars, Geir Kildahl-Andersen
  • COMPOUNDS
    Publication number: 20190284167
    Abstract: The invention provides compounds for use in a method of treating and/or preventing a bacterial infection in a human or non-human mammal, said method comprising administration of said compound in combination with (either simultaneously, separately, or sequentially) a ?-lactam antibiotic, wherein said compound has the general formula I: (I) (wherein: Q is a lipophilic, zinc chelating moiety which is selective for Zn2+ ions and which comprises at least one, preferably two or more (e.g 2, 3 or 4), optionally substituted, unsaturated heterocyclic rings, e.g.
    Type: Application
    Filed: August 15, 2017
    Publication date: September 19, 2019
    Inventors: Pål RONGVED, Ove Alexander Høgmoen ÅSTRAND, Ørjan SAMUELSEN, Christian SCHNAARS, Geir KILDAHL-ANDERSEN